Image

Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment

Recruiting
18 - 90 years of age
Both
Phase N/A

Powered by AI

Overview

PrevisEA is a noninvasive, disposable device that uses audio spectral analysis of sounds produced by the gastrointestinal tract to predict gastrointestinal impairment (GII). GII is most commonly associated with postoperative ileus (POI), but could be the result of other causes, such as early postoperative bowel obstruction. GII is defined as failure of successful early oral re-feeding in a subject undergoing major abdominal surgery. For subjects who are allowed to resume a diet during the first 24 hours after surgery, a failure to successfully orally re-feed a subject is defined as presentation with emesis, requiring a reversal of diet, or the placement of a nasogastric tube on first postoperative day or later.

The device is considered non-significant risk (NSR). The device does not inform medical decisions in this study. Researchers will be blinded to results of the device during this study.

Eligibility

Inclusion Criteria:

  1. Age ≥ 18 and ≤ 90 years
  2. Patient undergoing elective intestinal resection surgery including open, laparoscopic, robotic, or hand-assist technique for:
    1. Segmental ileocolic resection with or without diversion
    2. Segmental colon resection with or without diversion
    3. Segmental coloproctectomy with or without diversion
    4. Low anterior resection with or without diversion
    5. Abdominoperineal resection
    6. Total abdominal colectomy with or without diversion
    7. Proctocolectomy with or without end ileostomy or diversion
    8. Closure of end colostomy (Hartmann's reversal)

Exclusion Criteria:

  1. Allergies to any of the device components (i.e., adhesive)
  2. Inability to have prototype device applied to their abdominal wall due to disease conditions or surgical alterations(e.g., fistulas, stomas, drains, etc.)
  3. Patients undergoing:
    1. Small bowel resection without colonic resection
    2. Transanal proctectomy without transabdominal approach
    3. Perineal proctosigmoidectomy
    4. Closure of loop colostomy or ileostomy
  4. Patients with preoperative evidence of an anastomotic leak, deep wound infection,

    organ space infection, or urinary tract infection

Study details

Gastrointestinal Complication

NCT04880473

Entac Medical Inc.

19 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.